Riluzole Oral Soluble Film
Phase 2Withdrawn 0 watching 0 views this week⚡ Active
44
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedAbout Riluzole Oral Soluble Film
Riluzole Oral Soluble Film is a phase 2 stage product being developed by Aquestive Therapeutics for ALS. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT03457753. Target conditions include ALS.
Hype Score Breakdown
Clinical
17
Activity
12
Company
2
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03457753 | Phase 2 | Withdrawn |
Competing Products
20 competing products in ALS